WILMINGTON, Del., July 6, 2026 /PRNewswire/ -- Reprotech today announced that the TMRW Vault® has received CE marking as a Class IIa medical device under Regulation (EU) 2017/745, supporting commercialization in the European Union and other international markets that recognize the CE mark. The_TMRW_Vault_Workstation_Reprotech This achievement represents a major milestone for both the parent company, Reprotech, and the fertility industry, as the TMRW Vault combines digital chain-of-custody, advanced monitoring, and scalable cryostorage to help fertility clinics reduce risk, strengthen sREAD FULL ARTICLE
